BIOMAT Database Logo BIOMAT Database Logo

Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. 1995

J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Unité de Biologie Moléculaire du Gène, Institut National de la Santé et de la Recherche Medicale U277, Paris, France.

Major histocompatibility complex (MHC) class I molecules are cell-surface proteins that present peptides to CD8+ T cells. These peptides are mostly derived from endogenously synthesized protein. Recombinant, soluble MHC class I molecules were produced, purified, and loaded homogeneously with synthetic peptide. These MHC-peptide complexes were used to activate a T cell hybridoma. While monomers of MHC-peptide bound to the T cell, they showed no stimulatory activity. Dimers fully triggered the T cell hybridoma to secrete interleukin 2. This response was followed by a state in which the T cell was refractory to restimulation as a result of defective signal transduction through the T cell receptor.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D006183 H-2 Antigens The major group of transplantation antigens in the mouse. H2 Antigens,Antigens, H-2,Antigens, H2,H 2 Antigens
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
CD8+ cytotoxic T lymphocyte activation by soluble major histocompatibility complex-peptide dimers.
June 2005, The Journal of biological chemistry,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.
June 2000, Pharmaceutical research,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Localization of soluble major histocompatibility class II-peptide complexes on T cell surface.
September 2000, Microscopy research and technique,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Binding of T cell receptor to major histocompatibility complex class II-peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy).
December 1992, European journal of immunology,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex.
July 1996, Proceedings of the National Academy of Sciences of the United States of America,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.
May 1998, The Journal of experimental medicine,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor.
April 1992, Nature,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Peptide-major histocompatibility complex dimensions control proximal kinase-phosphatase balance during T cell activation.
September 2009, The Journal of biological chemistry,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice.
December 1992, Proceedings of the National Academy of Sciences of the United States of America,
J P Abastado, and Y C Lone, and A Casrouge, and G Boulot, and P Kourilsky
Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.
October 1997, The Journal of experimental medicine,
Copied contents to your clipboard!